ClinicalTrialsFinder

Anti-MDA5 Positive Dermatomyositis-Associated RP-ILD Clinical Trials in Guangzhou, Guangdong

1 recruitingGuangzhou, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial

Anti-MDA5 Positive Dermatomyositis-Associated RP-ILDRapidly Progressive Interstitial Lung Disease
Li Shiyue10 enrolled1 locationNCT06919380